RecruitingNot ApplicableNCT06788418

Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction


Sponsor

Beijing Visionly Plus Eye Hospital

Enrollment

1,000 participants

Start Date

Jan 20, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Myopia is a prevalent refractive error with significant lifestyle impact. While traditional SMILE (Small Incision Lenticule Extraction) and ICL (Implantable Collamer Lens) surgeries are standard options, the advent of the Wavelight Plus Alcon system presents a promising new technique. This trial aims to evaluate the safety, efficacy, and patient satisfaction across these methods.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Inclusion Criteria4

  • Adults aged 18-40 years
  • Spherical equivalent of -1.00 to -10.00 D
  • Stable refraction for at least 12 months
  • Informed consent provided

Exclusion Criteria4

  • Other ocular pathologies
  • Previous refractive surgery
  • Pregnancy or nursing
  • Autoimmune or connective tissue disorders

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREWavelight Plus Alcon system

Wavelight Plus Alcon system guided surgery for myopia

PROCEDURESMILE

Small Incision Lenticule Extraction surgery for myopia

PROCEDUREICL

Implantable Collamer Lens surgery for myopia


Locations(2)

Beijing New Vision Eye Hospital

Beijing, China

Beijing Visionly Plus Eye Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06788418


Related Trials